Загрузка видео...

Не удалось загрузить видео

Возникла проблема при загрузке этого видео. Это может быть связано с временными проблемами сети или видео может быть недоступно.

На главную

Why hasn’t nattokinase replaced statins? Joe Rogan discussed a study where 1,062 people took it for a year. Ultrasound showed their arterial plaque shrank 36%. This enzyme stops new blockages and reverses existing plaque. Why not mainstream yet?

healthbot

815,596 subscribers

709,259 просмотров • 4 месяцев назад •via X (Twitter)

Здоровье и велнес Наука и технологии

Anya Rossi• Live Now

Private livecam show

Комментарии: 0

Нет доступных комментариев

Здесь появятся комментарии из оригинального поста

Похожие видео

Joe Rogan recently talked about a study involving 1,062 participants who took nattokinase for a full year. According to the reported ultrasound findings, arterial plaque was reduced by roughly 36%. The enzyme is said to help prevent new blockages while also supporting the reduction of existing plaque buildup. Here’s a closer look at the data and dosage protocol: (1/12)

Joe Rogan recently talked about a study involving 1,062 participants who took nattokinase for a full year. According to the reported ultrasound findings, arterial plaque was reduced by roughly 36%. The enzyme is said to help prevent new blockages while also supporting the reduction of existing plaque buildup. Here’s a closer look at the data and dosage protocol: (1/12)

Shadow Intel

75,600 просмотров • 2 месяцев назад

A MAJOR study found nattokinase SHRANK arterial plaque by 36% with ZERO adverse effects. Among patients taking 10,800 FU daily for 12 months, 95.4% experienced some degree of cardiovascular improvement. The plaque reduction was objectively verified using carotid artery ultrasound. BB Maguire

A MAJOR study found nattokinase SHRANK arterial plaque by 36% with ZERO adverse effects. Among patients taking 10,800 FU daily for 12 months, 95.4% experienced some degree of cardiovascular improvement. The plaque reduction was objectively verified using carotid artery ultrasound. BB Maguire

Nicolas Hulscher, MPH

189,569 просмотров • 1 месяц назад

David Sinclair says he’s been reversing plaque in his arteries with nattokinase. On Peter Diamandis’ podcast, Sinclair shared that he’s been taking it for years and mentioned a Chinese study with 1,086 people that showed up to 95% plaque reduction in one year at sufficient doses (at least 12 fibrinolytic units daily). He also checks his own carotid arteries with ultrasound and says there’s no buildup. Nattokinase is an enzyme from fermented soybeans that breaks down fibrin. Some human studies show it can help reduce arterial plaque and improve blood flow, but results vary. Larger, high-quality trials are still limited, so it’s considered promising but not definitive. Cardiovascular disease is still the #1 killer. If there are accessible tools that support artery health beyond statins and lifestyle, it’s worth paying attention. Have you heard about nattokinase or tried anything similar for heart health?

David Sinclair says he’s been reversing plaque in his arteries with nattokinase. On Peter Diamandis’ podcast, Sinclair shared that he’s been taking it for years and mentioned a Chinese study with 1,086 people that showed up to 95% plaque reduction in one year at sufficient doses (at least 12 fibrinolytic units daily). He also checks his own carotid arteries with ultrasound and says there’s no buildup. Nattokinase is an enzyme from fermented soybeans that breaks down fibrin. Some human studies show it can help reduce arterial plaque and improve blood flow, but results vary. Larger, high-quality trials are still limited, so it’s considered promising but not definitive. Cardiovascular disease is still the #1 killer. If there are accessible tools that support artery health beyond statins and lifestyle, it’s worth paying attention. Have you heard about nattokinase or tried anything similar for heart health?

Camus

558,620 просмотров • 2 месяцев назад

Nattokinase can reduce arterial plaque by 36%. Joe Rogan was mind-blown talking to Michael Pollan about this supplement made from fermented soybeans (natto). It acts as a powerful natural clot-buster. High-dose nattokinase (around 10,800 FU/day) has been shown in clinical studies to reduce carotid artery plaque size by up to 36% and improve lipid profiles, with measurable results in as little as 12 months. A simple traditional fermented food might offer real cardiovascular benefits in a natural way. Have you tried nattokinase or any fermented foods for health reasons?

Nattokinase can reduce arterial plaque by 36%. Joe Rogan was mind-blown talking to Michael Pollan about this supplement made from fermented soybeans (natto). It acts as a powerful natural clot-buster. High-dose nattokinase (around 10,800 FU/day) has been shown in clinical studies to reduce carotid artery plaque size by up to 36% and improve lipid profiles, with measurable results in as little as 12 months. A simple traditional fermented food might offer real cardiovascular benefits in a natural way. Have you tried nattokinase or any fermented foods for health reasons?

Camus

68,005 просмотров • 2 месяцев назад

$David Sinclair just revealed one of the biggest studies on nattokinase. A comprehensive Chinese study of 1,067 people found that nattokinase reversed cardiovascular disease by removing up to 95% of arterial plaque in one year. This supplement is an enzyme from fermented soybeans and costs almost nothing. Sinclair has been taking it daily for a couple of years. He measures his carotid artery with ultrasound and says there's no plaque buildup at all. Peter Diamandis takes it too. He believes you need at least 6,000 fibrinolytic units per day to reap the benefits. For context: • Statins cost hundreds per month and come with side effects. • Surgical interventions can cost thousands of dollars Nattokinase costs a fraction of both. Sinclair's caveat: "Do this with the knowledge of your physician." But the data exists. A study of over 1,000 people and up to 95% plaque removal in just 12 months. And the man whose lab is reversing aging takes it every day. — David Sinclair (David Sinclair) on Peter Diamandis' (Peter H. Diamandis, MD) Moonshots podcast PS. David Sinclair is speaking at SynBioBeta on May 6th this year, discussing the science of slowing and reversing aging. If longevity is the world you're in, the investors, partners, and scientists shaping this space will be in the room. Grab your ticket in the comments below.$

David Sinclair just revealed one of the biggest studies on nattokinase. A comprehensive Chinese study of 1,067 people found that nattokinase reversed cardiovascular disease by removing up to 95% of arterial plaque in one year. This supplement is an enzyme from fermented soybeans and costs almost nothing. Sinclair has been taking it daily for a couple of years. He measures his carotid artery with ultrasound and says there's no plaque buildup at all. Peter Diamandis takes it too. He believes you need at least 6,000 fibrinolytic units per day to reap the benefits. For context: • Statins cost hundreds per month and come with side effects. • Surgical interventions can cost thousands of dollars Nattokinase costs a fraction of both. Sinclair's caveat: "Do this with the knowledge of your physician." But the data exists. A study of over 1,000 people and up to 95% plaque removal in just 12 months. And the man whose lab is reversing aging takes it every day. — David Sinclair (David Sinclair) on Peter Diamandis' (Peter H. Diamandis, MD) Moonshots podcast PS. David Sinclair is speaking at SynBioBeta on May 6th this year, discussing the science of slowing and reversing aging. If longevity is the world you're in, the investors, partners, and scientists shaping this space will be in the room. Grab your ticket in the comments below.

John Cumbers

841,064 просмотров • 4 месяцев назад

Dr. Ovadia says nattokinase is something he routinely recommends as part of his protocol for patients. It a fibrinolytic agent, meaning it helps the body break down blood clots as they start to form. He points to a trial showing reduced arterial plaque in patients taking it, though that study measured carotid (neck) plaque rather than coronary plaque, which he flags as a caveat. As mentioned below, the trial tested 3,600 units daily (not statistically significant) versus 10,800 units daily (significant plaque reduction), so he typically suggests around 10,000 units a day. He cautions that many supplements are dosed too low or poorly sourced, and that anyone on blood-thinning medication should talk to their doctor first. (h/t Ken D Berry MD & DoctorTro)

Dr. Ovadia says nattokinase is something he routinely recommends as part of his protocol for patients. It a fibrinolytic agent, meaning it helps the body break down blood clots as they start to form. He points to a trial showing reduced arterial plaque in patients taking it, though that study measured carotid (neck) plaque rather than coronary plaque, which he flags as a caveat. As mentioned below, the trial tested 3,600 units daily (not statistically significant) versus 10,800 units daily (significant plaque reduction), so he typically suggests around 10,000 units a day. He cautions that many supplements are dosed too low or poorly sourced, and that anyone on blood-thinning medication should talk to their doctor first. (h/t Ken D Berry MD & DoctorTro)

A Paradise for Parents

115,917 просмотров • 2 месяцев назад

There’s been a lot of buzz—and confusion—about the new Keto-CTA study, examining plaque progression in Lean Mass Hyper-Responders (LMHRs). Much of the social media debate has centered on whether high LDL on keto is safe or dangerous, driven largely by how to interpret the supplemental table comparing this study to others on LDL and plaque progression. In this episode of the Metabolic Mind Podcast, we sit down with Dr. Matthew Budoff, a world-renowned cardiologist, cardiac CT researcher, and the study's lead investigator, to discuss the the supplemental table, what the plaque markers mean, and how this fits into the discussion of high- vs -low-risk plaque progression. In this episode, we cover: ✅ What PAV (Percent Atheroma Volume) is, what it actually measures, and why it matters ✅ Why a 50% increase in plaque may sound scary, but can be deceiving ✅ The difference between “treatment-naive” and “treated” participants ✅ What the Miami Heart Study comparison reveals about keto, LDL, and plaque ✅ Why LDL alone may not tell the whole story about heart disease risk ✅ How some high-risk individuals may still benefit from statins and other therapies This study doesn’t answer whether keto causes heart disease or not. Instead, it shows that high LDL on a ketogenic diet is not a reliable predictor of plaque progression across all individuals. What is predictive? The presence of existing plaque. 💡 Key takeaway: Relying on surrogate markers of heart disease, like LDL and ApoB, is not the best way to assess heart disease risk in all populations. If you're concerned about how elevated LDL may be affecting your heart health, the best next step is to speak with your doctor about cardiac imaging to directly assess plaque and gain a clearer picture of your individual risk. Expert Featured: - Dr. Matthew Budoff - X: - Resources Mentioned: Plaque Begets Plaque, ApoB Does Not CMEs Mentioned: Managing Major Mental Illness with Dietary Change: The New Science of Hope Brain Energy: The Metabolic Theory of Mental Illness Follow our channel for more information and education from Bret Scher, MD, FACC, including interviews with leading experts in Metabolic Psychiatry. Learn more about metabolic psychiatry and find helpful resources at

There’s been a lot of buzz—and confusion—about the new Keto-CTA study, examining plaque progression in Lean Mass Hyper-Responders (LMHRs). Much of the social media debate has centered on whether high LDL on keto is safe or dangerous, driven largely by how to interpret the supplemental table comparing this study to others on LDL and plaque progression. In this episode of the Metabolic Mind Podcast, we sit down with Dr. Matthew Budoff, a world-renowned cardiologist, cardiac CT researcher, and the study's lead investigator, to discuss the the supplemental table, what the plaque markers mean, and how this fits into the discussion of high- vs -low-risk plaque progression. In this episode, we cover: ✅ What PAV (Percent Atheroma Volume) is, what it actually measures, and why it matters ✅ Why a 50% increase in plaque may sound scary, but can be deceiving ✅ The difference between “treatment-naive” and “treated” participants ✅ What the Miami Heart Study comparison reveals about keto, LDL, and plaque ✅ Why LDL alone may not tell the whole story about heart disease risk ✅ How some high-risk individuals may still benefit from statins and other therapies This study doesn’t answer whether keto causes heart disease or not. Instead, it shows that high LDL on a ketogenic diet is not a reliable predictor of plaque progression across all individuals. What is predictive? The presence of existing plaque. 💡 Key takeaway: Relying on surrogate markers of heart disease, like LDL and ApoB, is not the best way to assess heart disease risk in all populations. If you're concerned about how elevated LDL may be affecting your heart health, the best next step is to speak with your doctor about cardiac imaging to directly assess plaque and gain a clearer picture of your individual risk. Expert Featured: - Dr. Matthew Budoff - X: - Resources Mentioned: Plaque Begets Plaque, ApoB Does Not CMEs Mentioned: Managing Major Mental Illness with Dietary Change: The New Science of Hope Brain Energy: The Metabolic Theory of Mental Illness Follow our channel for more information and education from Bret Scher, MD, FACC, including interviews with leading experts in Metabolic Psychiatry. Learn more about metabolic psychiatry and find helpful resources at

Metabolic Mind

98,147 просмотров • 1 год назад

Dr. Stephen Hussey claims cardiology is way off base when it comes to heart disease and its plaque/cholesterol-based approach... and he brings receipts. Plaque in arteries causes heart attacks, right? Plaque is 87% clotting tissue and very little cholesterol. Half of people who had heart attacks had "normal cholesterol" levels. People who took statins had negligible absolute risk reductions. Plaque in arteries of 66% of heart attack patients in one study did not have obstructive plaque and some had no plaque at all. A study on stents failed to show any decreased incidence of heart attacks compared to people who didn't get stents. To be fair, the studies he cites (PMID's: 2035446, 19081406, 35285850, 38823406, 25601032, 14623791) are a drop in the bucket compared to the volume of science that supports the standard of care in Cardiology, but these studies (which are often funded by Big Pharma) should raise some serious concerns.

Dr. Stephen Hussey claims cardiology is way off base when it comes to heart disease and its plaque/cholesterol-based approach... and he brings receipts. Plaque in arteries causes heart attacks, right? Plaque is 87% clotting tissue and very little cholesterol. Half of people who had heart attacks had "normal cholesterol" levels. People who took statins had negligible absolute risk reductions. Plaque in arteries of 66% of heart attack patients in one study did not have obstructive plaque and some had no plaque at all. A study on stents failed to show any decreased incidence of heart attacks compared to people who didn't get stents. To be fair, the studies he cites (PMID's: 2035446, 19081406, 35285850, 38823406, 25601032, 14623791) are a drop in the bucket compared to the volume of science that supports the standard of care in Cardiology, but these studies (which are often funded by Big Pharma) should raise some serious concerns.

Cary Kelly

31,842 просмотров • 5 месяцев назад

Congress passed a law to place a plaque in the Capitol honoring the officers who protected the transfer of power, Members of Congress and VP Pence on Jan 6. The plaque is complete and long overdue for display. But Speaker Johnson is leaving it in a dark closet rather than honor those who protected him on that day. That’s why Rep. Jamie Raskin and House Democrats are placing replicas outside their doors until the official plaque is displayed in the Capitol where it belongs.

Congress passed a law to place a plaque in the Capitol honoring the officers who protected the transfer of power, Members of Congress and VP Pence on Jan 6. The plaque is complete and long overdue for display. But Speaker Johnson is leaving it in a dark closet rather than honor those who protected him on that day. That’s why Rep. Jamie Raskin and House Democrats are placing replicas outside their doors until the official plaque is displayed in the Capitol where it belongs.

House Judiciary Dems

163,196 просмотров • 1 год назад

Thank you Joe Rogan for having me back on Joe Roganhq This conversation goes deep. We talked about why LDL alone is not the enemy… Why the statin data is collapsing… And how most people over 60 are on 5+ prescriptions—without a single study on how they interact. 🎧 Watch here:

Thank you Joe Rogan for having me back on Joe Roganhq This conversation goes deep. We talked about why LDL alone is not the enemy… Why the statin data is collapsing… And how most people over 60 are on 5+ prescriptions—without a single study on how they interact. 🎧 Watch here:

Gary Brecka

65,560 просмотров • 1 год назад

I am in disbelief that this Congress still hasn’t found the political will to do something as basic, as decent, as installing a plaque to honor the law enforcement officers who protected the Capitol on January 6. Honoring the people who risked their lives for this institution should not be controversial. It should be automatic. And if we can’t agree to put up a plaque in their honor, what kind of example are we setting for the American people, for our kids, and for the next generation of officers who might one day be asked to stand between democracy and chaos? Put up the plaque. Show the country we still have a conscience. And show those officers and their families that their sacrifice wasn’t political. It was patriotic. It was noble. And it will never be forgotten.

I am in disbelief that this Congress still hasn’t found the political will to do something as basic, as decent, as installing a plaque to honor the law enforcement officers who protected the Capitol on January 6. Honoring the people who risked their lives for this institution should not be controversial. It should be automatic. And if we can’t agree to put up a plaque in their honor, what kind of example are we setting for the American people, for our kids, and for the next generation of officers who might one day be asked to stand between democracy and chaos? Put up the plaque. Show the country we still have a conscience. And show those officers and their families that their sacrifice wasn’t political. It was patriotic. It was noble. And it will never be forgotten.

Rep. Mike Levin

122,413 просмотров • 7 месяцев назад

JOE ROGAN: WHY DO PEOPLE GET MAD AT DICAPRIO FOR DATING YOUNG WOMEN? "What's fascinating to me is that people get mad at him for dating 19-year-olds because he's 50. It's a giant difference but here's the thing if it was a 19-year-old guy and a 48-year-old woman everyone would be like - you go girl.” Source: Joe Rogan

JOE ROGAN: WHY DO PEOPLE GET MAD AT DICAPRIO FOR DATING YOUNG WOMEN? "What's fascinating to me is that people get mad at him for dating 19-year-olds because he's 50. It's a giant difference but here's the thing if it was a 19-year-old guy and a 48-year-old woman everyone would be like - you go girl.” Source: Joe Rogan

Mario Nawfal

2,693,472 просмотров • 1 год назад

Tim Dillon, Joe Rogan discuss why Israel's anti-terrorism response took so long on October 7, 2023 Rogan: "Why did it take so long to respond to that?" Dillon: "Well, this is another very interesting, very important question" "Because there's a lot of people that say it's a state the size of New Jersey. And the security failures are... pretty wild. And there hasn't been a real investigation into them" "And Netanyahu's kinda prevented that. And they've kinda made it illegal to question that in Israel...." "And by the way, that's not the only thing that should be looked into. Look into Butler. Look into everything!" "Where are the 9/11 docs? What happened? Can we know? Why can't we know anything?" Joe Rogan Tim Dillon

Tim Dillon, Joe Rogan discuss why Israel's anti-terrorism response took so long on October 7, 2023 Rogan: "Why did it take so long to respond to that?" Dillon: "Well, this is another very interesting, very important question" "Because there's a lot of people that say it's a state the size of New Jersey. And the security failures are... pretty wild. And there hasn't been a real investigation into them" "And Netanyahu's kinda prevented that. And they've kinda made it illegal to question that in Israel...." "And by the way, that's not the only thing that should be looked into. Look into Butler. Look into everything!" "Where are the 9/11 docs? What happened? Can we know? Why can't we know anything?" Joe Rogan Tim Dillon

Sense Receptor

73,780 просмотров • 2 месяцев назад

Joe Rogan: "The only reason why there is this [ICE] problem is because we had a f*cking open border for four years where they actually encouraged people to come in, and they let in a bunch of violent criminals."

Joe Rogan: "The only reason why there is this [ICE] problem is because we had a f*cking open border for four years where they actually encouraged people to come in, and they let in a bunch of violent criminals."

Joe Rogan Podcast News

101,438 просмотров • 1 месяц назад

For those people asking what is Kamala Harris’s Black agenda, and why hasn’t she done it yet, it’s time to create realistic expectations about what a president can and cannot do. My new Word In Black post:

For those people asking what is Kamala Harris’s Black agenda, and why hasn’t she done it yet, it’s time to create realistic expectations about what a president can and cannot do. My new Word In Black post:

Keith Boykin

60,924 просмотров • 2 лет назад

What if everything we thought we knew about cholesterol and heart disease risk… doesn’t apply to everyone? In this episode, world-renowned cardiologist Dr. Matthew Budoff unpacks the results of a landmark one-year study tracking 100 lean, metabolically healthy individuals on a ketogenic diet with extremely elevated LDL levels. Dr. Budoff is the Program Director, Director of Cardiac CT, and the endowed chair of preventive cardiology at The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center. In this interview, Dr. Scher and Dr. Budoff further break down the results of his new publication, which used advanced imaging to demonstrate that LDL cholesterol and ApoB levels are not associated with plaque progression in Lean-Mass Hyper Responders following a #ketogenicdiet. 📊 Surprising insights: • Elevated LDL and ApoB did not predict plaque progression • Some participants with LDLs over 500 showed no plaque at all • A few participants even experienced plaque regression • Existing plaque—not LDL-C or ApoB—did predict plaque accumulation in this population Dr. Budoff explains what these results mean for clinicians, for patients using ketogenic therapy as a medical intervention, and for the broader conversation around cardiovascular disease risk. “It is important that clinicians, along with the general public, are made aware that personalized, data-driven approaches to assessing risk should be considered based on individual conditions,” said Dr. Budoff. “The existence of this phenotype suggests that alternative markers or tests should be used to establish metabolic health in some cases.” 🎬 These exciting new findings are featured in Dave Feldman and Jen Isenhart’s upcoming documentary, The Cholesterol Code, the story of how a software engineer conducts a groundbreaking study on an unusual group of people—lean, healthy individuals whose doctors are convinced they’ll die young. Real stories of healing with ketogenic diets provide a blueprint for using food as powerful medicine. Visit to learn more about the film and to be the first to hear about private screenings and the general release in the fall. Expert Featured: Dr. Matthew Budoff Matthew Budoff MD Resources Mentioned: Plaque Begets Plaque, ApoB Does Not Diagnostic and Preventative Cardiovascular Imaging Center CMEs Mentioned: Managing Major Mental Illness with Dietary Change: The New Science of Hope Brain Energy: The Metabolic Theory of Mental Illness Learn more about metabolic psychiatry and find helpful resources at

What if everything we thought we knew about cholesterol and heart disease risk… doesn’t apply to everyone? In this episode, world-renowned cardiologist Dr. Matthew Budoff unpacks the results of a landmark one-year study tracking 100 lean, metabolically healthy individuals on a ketogenic diet with extremely elevated LDL levels. Dr. Budoff is the Program Director, Director of Cardiac CT, and the endowed chair of preventive cardiology at The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center. In this interview, Dr. Scher and Dr. Budoff further break down the results of his new publication, which used advanced imaging to demonstrate that LDL cholesterol and ApoB levels are not associated with plaque progression in Lean-Mass Hyper Responders following a #ketogenicdiet. 📊 Surprising insights: • Elevated LDL and ApoB did not predict plaque progression • Some participants with LDLs over 500 showed no plaque at all • A few participants even experienced plaque regression • Existing plaque—not LDL-C or ApoB—did predict plaque accumulation in this population Dr. Budoff explains what these results mean for clinicians, for patients using ketogenic therapy as a medical intervention, and for the broader conversation around cardiovascular disease risk. “It is important that clinicians, along with the general public, are made aware that personalized, data-driven approaches to assessing risk should be considered based on individual conditions,” said Dr. Budoff. “The existence of this phenotype suggests that alternative markers or tests should be used to establish metabolic health in some cases.” 🎬 These exciting new findings are featured in Dave Feldman and Jen Isenhart’s upcoming documentary, The Cholesterol Code, the story of how a software engineer conducts a groundbreaking study on an unusual group of people—lean, healthy individuals whose doctors are convinced they’ll die young. Real stories of healing with ketogenic diets provide a blueprint for using food as powerful medicine. Visit to learn more about the film and to be the first to hear about private screenings and the general release in the fall. Expert Featured: Dr. Matthew Budoff Matthew Budoff MD Resources Mentioned: Plaque Begets Plaque, ApoB Does Not Diagnostic and Preventative Cardiovascular Imaging Center CMEs Mentioned: Managing Major Mental Illness with Dietary Change: The New Science of Hope Brain Energy: The Metabolic Theory of Mental Illness Learn more about metabolic psychiatry and find helpful resources at

Metabolic Mind

10,423 просмотров • 1 год назад

Who’s better at managing their money, the people or the government? In Arkansas, we believe it’s the people. That’s why my administration has cut taxes not once, not twice, but three times - and why we’re gearing up for a fourth tax cut this year.

Who’s better at managing their money, the people or the government? In Arkansas, we believe it’s the people. That’s why my administration has cut taxes not once, not twice, but three times - and why we’re gearing up for a fourth tax cut this year.

Sarah Huckabee Sanders

48,711 просмотров • 4 месяцев назад

NEW - Joe Rogan on Trump and Iran war: "It just seems so insane based on what he ran on. This is why a lot of people feel betrayed. He ran on no more wars and these stupid, senseless wars. And then we have one that we can't even really clearly define why we did it."

NEW - Joe Rogan on Trump and Iran war: "It just seems so insane based on what he ran on. This is why a lot of people feel betrayed. He ran on no more wars and these stupid, senseless wars. And then we have one that we can't even really clearly define why we did it."

Insider Paper

46,860 просмотров • 5 месяцев назад

Democrats are furious that Joe Rogan was standing behind President Trump in the Oval Office today. Trump said, “Joe Rogan is a fantastic person. We did a little interview before the election. We had over 300 million people. And I said, ‘Oh man, I hope Kamala doesn’t do it.’ And she didn’t. He wanted her to do it but she didn’t. Someday Joe’s going to explain why. I could tell you why—because she didn’t want to.” Kamala not going on Rogan was a costly mistake for her chances in the 2024 presidential election. Democrats know this. So when they see Joe Rogan with President Trump, they’re triggered like nothing else. Just search their comments today about this. They’re so unhinged. It’s awesome.

Democrats are furious that Joe Rogan was standing behind President Trump in the Oval Office today. Trump said, “Joe Rogan is a fantastic person. We did a little interview before the election. We had over 300 million people. And I said, ‘Oh man, I hope Kamala doesn’t do it.’ And she didn’t. He wanted her to do it but she didn’t. Someday Joe’s going to explain why. I could tell you why—because she didn’t want to.” Kamala not going on Rogan was a costly mistake for her chances in the 2024 presidential election. Democrats know this. So when they see Joe Rogan with President Trump, they’re triggered like nothing else. Just search their comments today about this. They’re so unhinged. It’s awesome.

Paul A. Szypula 🇺🇸

14,350 просмотров • 4 месяцев назад